Loading interface...

Glycolate 2 Tablet

Manufactured byINTAS PHARMACEUTICALS LTD
Description

Glycolate 2 Tablet is a synthetic anticholinergic agent used in anesthesia for reducing the production of gastric acid, salivation, etc. and It is used for treating chronic obstructive pulmonary disease also to reduce drooling in children between 3-16 years of age. It is also used as an adjunctive for treating the peptic ulcers.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Side effects

Major & minor side effects for Glycolate 2 Tablet

  • Constipation
  • Decrease in the frequency of urination
  • Ear congestion
  • Difficulty in breathing
  • Nasal congestion
  • Unsual tiredness or weakness
  • Dizziness
  • Increase in heart rate
  • Abdominal discomfort
  • Fainting
  • Vomiting
  • Shortness of breath
  • Chest tightness

Uses of Glycolate 2 Tablet

What is it prescribed for?

  • Anesthesia
  • Peptic Ulcer
  • Excessive salivation
  • Chronic obstructive pulmonary disease (COPD)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 minute of intravenous administration and 15-30 minutes upon intramuscular/subcutaneous administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains effective in the body is subject to vary based on the intended use and route of administration.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended while receiving this medicine as it may increase the risk of adverse effects. Avoid performing activities that need high mental alertness like driving a vehicle or operating heavy machinery if alcohol and this medicine are used together.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to glycopyrrolate, or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.
General warnings

Driving or operating machinery

Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of adverse effects. Regular monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hyperthyroidism

This medicine should be used with caution in patients with hyperthyroidism due to the increased risk of adverse effects. Regular monitoring of thyroid function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Missed Dose

Oral forms: Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Injection: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Oral forms: Seek emergency medical treatment or contact the doctor in case of an overdose. Injection: Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended while receiving this medicine as it may increase the risk of adverse effects. Avoid performing activities that need high mental alertness like driving a vehicle or operating heavy machinery if alcohol and this medicine are used together.
Interaction with Medicine

Potassium Chloride

Topiramate

Clozapine

Dicyclomine

Zonisamide

Disease interactions

Arrhythmias

This medicine should be used with extreme caution in patients who are suffering from arrhythmia due to the increased risk of worsening of the patient's condition. An alternative treatment option should be required in some cases based on the clinical condition.

Glaucoma

This medicine should be used with extreme caution in patients who are suffering from glaucoma due to the increased risk of worsening of the patient's condition. An alternative treatment option should be required in some cases based on the clinical condition.

Obstructive uropathy

This medicine is not recommended for use in patients who are suffering from obstructive uropathy due to the increased risk of worsening of the patient's condition. An alternative treatment option should be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Oral forms: Take this medicine as instructed by the doctor. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. It is advised to do regular follow-ups with the doctor while taking this medicine. Injection: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

To be taken on an empty stomach

To be taken as instructed by doctor

May cause sleepiness

How it works
It works by blocking the action of certain chemicals in the body, thereby reducing the production of stomach acid and saliva.
Legal Status

Approved

Approved

Approved

Unknown

Classification

Category

Anticholinergics/antispasmodics

Schedule

Schedule H

TGA eBS - Product and Consumer Medicine Information Licence [Internet]. Ebs.tga.gov.au. 2018 [cited 6 October 2018]. Available from:

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2016-PI-02193-1&d=201810061016933

DailyMed - GLYCOPYRROLATE- glycopyrrolate injection [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 6 October 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbab4cf1-0441-4fc4-9de9-e4117fa19faa

Glycopyrrolate: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2019 [cited 11 September 2019]. Available from:

https://medlineplus.gov/druginfo/meds/a602014.html

Glycopyrronium - DrugBank [Internet]. Drugbank.ca. 2019 [cited 11 September 2019]. Available from:

https://www.drugbank.ca/drugs/DB00986

Glycopyrronium Bromide 200 micrograms/ml Solution for Injection - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2019 [cited 11 September 2019]. Available from:

https://www.medicines.org.uk/emc/product/2786/smpc
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Sep 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.